ECIA.US Encision Inc
- Market cap
- USD 247K
- P/E
- -
- P/B
- 0.13x
- ROE
- -2.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.
Is ECIA.US undervalued?
Graham numberThe Graham number of Encision Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Encision Inc fundamental analysis
No fundamental analysis for Encision Inc yet.
Encision Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Encision Inc
Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. It operates through two segments, Product and Service. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. The AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers…
Full company profileEncision Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Encision Inc annual financial statements
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 8.87M | 8.75M | 8.80M | 7.67M | 7.54M | 7.67M | 7.35M | 6.59M | 6.56M | 5.78M | 4.78M |
| Gross Profit | 4.41M | 5.01M | 4.67M | 4.00M | 3.91M | 3.79M | 4.03M | 3.14M | 3.51M | 2.71M | 2.24M |
| Operating Income | -688K | 396K | -186K | -156K | -61.0K | -595K | -303K | -641K | -172K | -637K | 9.55K |
| EBITDA | -445K | 599K | -3.69K | -17.1K | 761K | 55.1K | -218K | -544K | -95.1K | -543K | 107K |
| Net Income | -729K | 336K | -236K | -241K | 585K | 463K | -366K | -692K | -220K | -719K | -33.9K |
| EPS | -0.07 | 0.03 | -0.02 | -0.02 | 0.05 | 0.04 | -0.03 | -0.06 | -0.02 | -0.05 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 3.07M | 3.25M | 3.43M | 4.74M | 5.66M | 4.79M | 4.13M | 3.81M | 3.67M | 3.70M | 3.45M |
| Total Liabilities | 1.27M | 1.05M | 1.08M | 2.55M | 2.86M | 2.05M | 1.64M | 1.98M | 2.02M | 2.27M | 1.96M |
| Shareholders' Equity | 1.80M | 2.20M | 2.35M | 2.18M | 2.80M | 2.75M | 2.50M | 1.83M | 1.65M | 1.43M | 1.50M |
| Cash & Short-term Investments | 45.0K | 115K | 273K | 385K | 1.47M | 950K | 189K | 42.5K | 257K | 245K | 275K |
| Total Debt | 275K | 10.1K | 74.8K | 1.79M | 2.00M | 1.15M | 1.08M | 1.33M | 1.31M | 1.70M | 1.42M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 23.0K | 420K | -127K | -229K | 220K | -444K | -861K | 144K | -54.9K | -384K | 59.4K |
| Capital Expenditure | 133K | 100K | 60.8K | 54.0K | 45.0K | 36.0K | 183K | 36.8K | 80.0K | 43.2K | 20.8K |
| Free Cash Flow | -110K | 320K | -188K | -283K | 175K | -480K | -1.04M | 108K | -135K | -428K | 59.4K |
| Ratios | |||||||||||
| ROE | -40.5% | 15.2% | -10.0% | -11.1% | 20.9% | 16.9% | -14.7% | -37.9% | -13.3% | -50.2% | -2.3% |
| ROA | -23.8% | 10.3% | -6.9% | -5.1% | 10.3% | 9.7% | -8.9% | -18.2% | -6.0% | -19.4% | -1.0% |
| Net Profit Margin | -8.2% | 3.8% | -2.7% | -3.1% | 7.8% | 6.0% | -5.0% | -10.5% | -3.4% | -12.4% | -0.7% |
| Debt to Equity | 0.15x | 0.00x | 0.03x | 0.82x | 0.71x | 0.42x | 0.43x | 0.73x | 0.80x | 1.19x | 0.95x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Encision Inc dividends
Encision Inc has not paid dividends in the last 9 fiscal years.
Who owns Encision Inc
- Insiders 57.26%
- Institutions 5.11%
- Public & others 37.63%
- Shares outstanding 18.9M
- Free float 6.43M
Encision Inc company profile
- Company name
- Encision Inc
- Ticker
- ECIA.US
- Exchange
- USA Stocks
- Listed since
- Jun 25, 1996
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 22
- Fiscal year end
- March
- Address
- 6797 Winchester Circle, Boulder, CO, United States, 80301
- Phone
- 303 444 2600
- Website
- encision.com
About Encision Inc
Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. It operates through two segments, Product and Service. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. The AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. It also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; AEM EndoShield 2 burn protection systems; AEM 2X enTouch scissors; and electrical engineering activities for external entities. In addition, the company markets AEM monitor product line that is used in conjunction with AEM instruments. It sells its products through a network of direct and independent sales representatives. The company was formerly known as Electroscope Inc and changed its name to Encision Inc. in August 2000. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.
Encision Inc management
3- Mr. Robert H. FriesInterim President, CEO & Director · born 1949
- Mr. Jason E. JohnsonVice President of Sales · born 1975
- Mr. David W. NewtonCo-Founder · born 1947